Diagnostic Test & Biomarker Research for Alzheimer's Disease

Research into diagnostic test & biomarker research approaches for Alzheimer's Disease. AI-powered analysis of mechanisms, evidence, and clinical status.

About Diagnostic Test & Biomarker Research

Research into diagnostic tests, biomarkers, imaging modalities, liquid biopsies, and laboratory panels for disease evaluation, staging, and treatment monitoring. Focused on identifying the most informative tests for each clinical scenario.

About Alzheimer's Disease

2026 Alzheimer's breakthroughs: at-home Leqembi, pill-based therapies in trials, brain stimulation devices. AI-analyzed with safety scores and PubMed citations.

Standard of Care: Lecanemab (Leqembi), Donanemab — anti-amyloid antibodies. Cholinesterase inhibitors (donepezil, rivastigmine) for symptom management.